Cetuximab funded for some bowel cancer patients from 1 November 2024
October 10, 2024
GCF is delighted to see today’s announcement that Erbitux Cetuximab (Erbitux) will be funded for a group of bowel cancer patients.From November 1st, this targeted treatment will be available for patients with metastatic colorectal cancer on the left side of the colon, with...
TAGS
Pancreatic Cancerclinical trialPanCan GalaPancreasresearchShine A LightauctionBig Purple Dinnerbowel cancercancer drugsCancer preventionCDH1Gastric Cancergut microbiomeHereditary Diffuse Gastric CancermedicinesmicrobiomePancare FoundationPancreatic Cancer Awareness MonthPatient Supportpharmacstomach cancerstomach cancer awarenessstomach cancer awareness weektreatment access